Healthcare Sales & Marketing Network News: percutaneous coronary intervention

Searching News Database: percutaneous coronary intervention

HSMN NewsFeed - 23 Jul 2024
Magenta Medical Closes $105M Financing Led by Novo Holdings
Devices Interventional Cardiology Venture Capital

HSMN NewsFeed - 11 Mar 2024
PulseCath Achieves MDR CE Certification for iVAC 2L, Paving the Way for Complex High-Risk Percutaneous Coronary Interventions
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 1 Mar 2024
Boston Scientific Receives FDA Approval for the AGENT(TM) Drug-Coated Balloon
Devices Interventional Cardiology FDA

HSMN NewsFeed - 16 Sep 2022
Supira Medical Announces Successful First-In-Human Use Of Its Next Generation Percutaneous Ventricular Assist Device
Devices Interventional Cardiology

HSMN NewsFeed - 12 Apr 2022
FDA Clears Four New Coronary Micro Support Catheters
Devices Interventional Cardiology FDA

HSMN NewsFeed - 26 Jul 2021
Medtronic Launches Newest-Generation Drug Coated Balloon Catheter in Europe for Treatment of Coronary Artery Disease
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 29 Jan 2020
CytoSorb(R) is Approved and Available for the Removal of Ticagrelor, a Leading Anti-Platelet Drug, During Cardiopulmonary Bypass in the E.U.
Devices Regulatory Product Launch

HSMN NewsFeed - 20 Sep 2019
CHMP Issues Positive Opinion to Expand Trulicity(R) (dulaglutide) Label to Include Results from REWIND Cardiovascular Outcomes Trial
Biopharmaceuticals Endocrinology Cardiology Regulatory

HSMN NewsFeed - 18 Sep 2019
Boston Scientific Announces Scheduled Presentations at Transcatheter Cardiovascular Therapeutics 2019
Devices Interventional Cardiology

HSMN NewsFeed - 6 Aug 2019
CeloNova Announces Appointment of New President and CEO
Devices Interventional Cardiology Personnel

HSMN NewsFeed - 13 Jun 2019
Terumo Enhances Coronary Interventional Product Portfolio By Securing Exclusive Global Rights to Orchestra BioMed's Virtue(R) Sirolimus-Eluting Balloon (SEB) through Global Strategic Partnership
Devices Interventional Licensing

HSMN NewsFeed - 10 Apr 2019
BIOTRONIK Launches PK Papyrus Covered Coronary Stent in the USA
Devices Interventional Cardiology Product Launch

HSMN NewsFeed - 4 Sep 2018
Miracor Medical closes final tranche of Series-D, bringing the round to €30M
Devices Interventional Cardiology Venture Capital

HSMN NewsFeed - 28 Aug 2018
Daiichi Sankyo Presents First Snapshot Analyses from Global ETNA-AF Programme of Oral, Once-daily LIXIANA(R) (edoxaban) in Patients with Nonvalvular Atrial Fibrillation in Routine Clinical Practice
Biopharmaceuticals

HSMN NewsFeed - 13 Aug 2018
New Analysis Identifies Patient Populations With Cancer-associated VTE Who Could Benefit From Treatment With Oral, Once-daily LIXIANA(R) (edoxaban)
Biopharmaceuticals

HSMN NewsFeed - 23 Jul 2018
MEDICALgorithmics, Medi-Lynx Receive FDA 510(K) Clearance for PocketECG CRS Mobile Cardiac Rehabilitation System
Devices Monitoring Cardiology FDA

HSMN NewsFeed - 23 May 2018
Newest Generation of Leading Heart Stent is Now Approved in the U.S. for People with Coronary Artery Disease
Devices Interventional Cardiology FDA

HSMN NewsFeed - 22 May 2018
Five-Year Study Data Confirm Positive Outcomes for Patients When Abbott Diagnostic Tool Was Used to Guide Heart Stenting Decisions
Devices Interventional Cardiology

HSMN NewsFeed - 22 May 2018
FAST Study Demonstrates High Diagnostic Accuracy of CAAS vFFR and Received USA 510(k) Market Clearance
Devices Interventional Cardiology FDA

HSMN NewsFeed - 30 Mar 2018
Abiomed to Appoint New Chief Financial Officer Todd A. Trapp
Devices Cardiology Personnel

HSMN NewsFeed - 26 Feb 2018
Medtronic Launches First 2.0 mm Drug-Eluting Stent in United States Designed to Treat Patients with Small Vessels
Devices Interventional Cardiology Product Launch

HSMN NewsFeed - 13 Feb 2018
Abiomed Receives Approval for Expanded FDA Indication for Cardiomyopathy with Cardiogenic Shock
Devices Cardiology FDA

HSMN NewsFeed - 30 Nov 2017
Cordis and Medinol Announce FDA Approval of the Innovative EluNIR Drug-Eluting Stent System
Devices Interventional Cardiology FDA

HSMN NewsFeed - 30 Oct 2017
Abbott Introduces Next Generation of Most Widely Used Heart Stent for People with Coronary Artery Disease in Europe[1]
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 28 Aug 2017
ESC Congress 2017: BIOTRONIK's Orsiro Drug-Eluting Stent Outperforms Xience in BIOFLOW-V Trial
Devices Interventional Cardiology

HSMN NewsFeed - 25 Jul 2017
Roxwood Medical Announces Agreement with Abbott for Distribution of Products in U.S.
Devices Interventional Cardiology Distribution

HSMN NewsFeed - 17 Jul 2017
CHMP Issues a Positive Opinion for Daiichi Sankyo's Once-Daily LIXIANA(R) (edoxaban) in Patients with Atrial Fibrillation Undergoing Cardioversion
Biopharmaceuticals Cardiology Regulatory

HSMN NewsFeed - 16 May 2017
Micell Technologies Announces MiStent Achieved Primary Endpoint in All-Comers Randomized Clinical Trial Versus Xience
Devices Interventional Cardiology

HSMN NewsFeed - 14 Mar 2017
Teleflex (TFX) Announces 510(k) Clearance and U.S. Launch of Spectre(TM) Guidewire
Devices Interventional Cardiology FDA Product Launch

HSMN NewsFeed - 9 Mar 2017
New Study Finds Abiomed Impella(R) Heart Pump Reduces Injury to Kidneys During High-Risk Percutaneous Coronary Intervention
Devices Interventional Cardiology

HSMN NewsFeed - 28 Feb 2017
RenalGuard(R) Shown to Significantly Protect High-Risk Patients Undergoing Coronary Interventional Procedures from Acute Kidney Injury
Devices Interventional

HSMN NewsFeed - 16 Feb 2017
Corindus Vascular Robotics Announces Strategic Distribution Partnership with MC Healthcare Group Granting Exclusive Rights to Distribute the CorPath(R) GRX System in Japan
Devices Interventional Distribution

HSMN NewsFeed - 2 Nov 2016
Cardinal Health Announces New Strategic Distribution Agreements to Expand Cordis' Cardiovascular Product Offerings in Asia Pacific
Devices Cardiology Distribution

HSMN NewsFeed - 25 Oct 2016
Miracor Receives Additional Funding in Series-C Closing to Expand Clinical and Commercial Activities with the PiCSO(R) Impulse System
Devices Interventional Cardiology Venture Capital

HSMN NewsFeed - 20 Oct 2016
Corindus Vascular Robotics Appoints Jeff Lemaster Chief Commercial Officer
Devices Interventional Personnel

HSMN NewsFeed - 13 Oct 2016
Corindus Vascular Robotics Appoints Suzette Jaskie Vice President Global Medical Affairs
Devices Personnel

HSMN NewsFeed - 10 Oct 2016
St. Jude Medical Announces FDA Clearance and Launch of the New PressureWire X Guidewire Designed to Optimize PCI Procedures in Patients With Complex Anatomies
Devices Interventional Cardiology FDA Product Launch

HSMN NewsFeed - 18 May 2016
St. Jude Medical Announces European Launch of the Latest in PressureWire Guidewire Technology to Measure Pressure Differences Across Narrowed Coronary Arteries
Devices Interventional Cardiology Product Launch

HSMN NewsFeed - 15 Dec 2015
Svelte Medical Systems Announces CE Mark Certification of SLENDER IDS(TM)
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 5 Nov 2015
TherOx Receives FDA IDE Approval for Study of Next-Generation Supersaturated Oxygen Therapy for AMI
Devices Interventional Cardiology FDA

HSMN NewsFeed - 12 Oct 2015
Abbott Announces Positive Clinical Results of Absorb(TM), the Naturally Dissolving Heart Stent
Devices Interventional Cardiology

HSMN NewsFeed - 6 Oct 2015
FDA Clears CorPath(R) System for Robotic-assisted Radial Access PCI Procedures
Devices Interventional Cardiology FDA

HSMN NewsFeed - 5 Oct 2015
Boston Scientific Receives FDA Approval For SYNERGY(TM) Bioabsorbable Polymer Drug-Eluting Stent System
Devices Interventional Cardiology FDA

HSMN NewsFeed - 21 Sep 2015
Miracor Medical Systems Launches PiCSO(R) Impulse System in Asia
Devices Interventional Cardiology Product Launch

HSMN NewsFeed - 4 Sep 2015
Thoratec Announces Start Of Shield II(TM) U.S. Clinical Trial
Devices Interventional Cardiology

HSMN NewsFeed - 23 Jul 2015
St. Jude Medical and Thoratec Announce Definitive Agreement
Devices Cardiology Mergers & Acquisitions

HSMN NewsFeed - 13 Jul 2015
Thoratec Receives CE Mark Approval For HeartMate PHP(TM)
Devices Cardiology Regulatory

HSMN NewsFeed - 9 Jul 2015
The Medicines Company Authorizes Generic Launch of ANGIOMAX(R) (bivalirudin)
Biopharmaceuticals Generics Product Launch

HSMN NewsFeed - 23 Jan 2015
The Medicines Company Receives CHMP Positive Opinions for Three Hospital Acute Care Products: KENGREXAL(TM) (cangrelor), ORBACTIV(TM) (oritavancin) and RAPLIXA(TM) (sealant powder)
Biopharmaceuticals Regulatory

HSMN NewsFeed - 18 Dec 2014
The Medicines Company and SciClone Pharmaceuticals Establish Strategic Partnership for Two Cardiovascular Products in China
Biopharmaceuticals Cardiology Licensing

HSMN NewsFeed - 18 Sep 2014
World’s First Integrated Delivery System Meets All Endpoints in the Direct II Randomized, Controlled Drug-Eluting Coronary Stent Study
Devices Interventional Cardiology

HSMN NewsFeed - 4 Sep 2014
EndoCross Receives CE Mark Approval for the ENABLER-C Coronary Catheter System for the Crossing of Coronary Chronic Total Occlusions
Devices INterventional Cardiology Regulatory

HSMN NewsFeed - 19 Aug 2014
Boston Scientific and ASAHI INTECC Announce Joint Development and Manufacturing Programs
Devices Interventional Cardiology

HSMN NewsFeed - 24 Jul 2014
Boston Scientific Receives CE Mark For Agent(TM) Drug-Coated Balloon
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 12 Jun 2014
Cardiovascular Systems Announces Plans for New Corporate Headquarters
Devices Interventional Cardiology

HSMN NewsFeed - 23 Dec 2013
European Medicines Agency Accepts Marketing Authorization Application for The Medicines Company's Cangrelor
Biopharmaceuticals Cardiology Regulatory

HSMN NewsFeed - 9 Dec 2013
Regado Biosciences Strengthens Executive Leadership
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Dec 2013
Physicians Throughout U.S. Using Cardiovascular Systems’ New Technology to Treat Coronary Artery Disease
Devices Interventional Cardiology Product Launch

HSMN NewsFeed - 4 Nov 2013
Supersaturated Oxygen Therapy IDE Study Results in Smaller Infarct Size for Next-Generation System
Devices Interventional Cardiology

HSMN NewsFeed - 30 Oct 2013
The Medicines Company's EUROMAX Trial of Angiox(R) (Bivalirudin) in Heart Attack Meets All Prespecified Endpoints
Biopharmaceuticals Cardiology

HSMN NewsFeed - 22 Oct 2013
Cardiovascular Systems, Inc. Receives Coronary FDA Approval
Devices Interventional Cardiology FDA Product Launch

HSMN NewsFeed - 9 Oct 2013
First Patient Enrolled in Phase III Trial Evaluating The Medicines Company's Angiomax(R) (Bivalirudin) in Patients Undergoing Peripheral Endovascular Procedures
Biopharmaceuticals Interventional

HSMN NewsFeed - 22 Aug 2013
Infraredx Receives $25 Million Investment from Nipro Corporation
Devices Interventional Cardiology Venture Capital

HSMN NewsFeed - 6 Aug 2013
First Patients Enrolled in REMEDEE Registry to Evaluate Long-Term Safety and Performance of OrbusNeich's COMBO Dual Therapy Stent(TM) in Routine Practice
Devices Interventional Cardiology

HSMN NewsFeed - 31 Jul 2013
New Sub-Analysis of PLATO ACS Study Suggests Patient Types and Stent Types Had No Impact on Findings of Reduced Rate of Stent Thrombosis With BRILINTA (ticagrelor)
Biopharmaceuticals Devices Interventional Cardiology

HSMN NewsFeed - 30 Jul 2013
Multicenter Study Finds Cost Savings Associated With Coronary Interventions Via Transradial (Wrist) Access Exceed $800 Per Procedure Versus Transfemoral (Groin) Access
Devices Interventional Cardiology

HSMN NewsFeed - 24 Jul 2013
Boston Scientific Launches OptiCross(TM) Coronary Imaging Catheter in U.S., Europe and Japan
Devices Interventional Cardiology FDA Product Launch

HSMN NewsFeed - 18 Jul 2013
First Robotic-Assisted Stent Placement in Acute Heart-Attack Patient Performed at Sanford Aberdeen Medical Center
Devices Interventional Cardiology

HSMN NewsFeed - 12 Jul 2013
Boston Scientific Launches Guidezilla(TM) Guide Extension Catheter in U.S. and Europe
Devices Interventional Cardiology FDA Product Launch

HSMN NewsFeed - 10 Jul 2013
STENTYS Self-Apposing Stent Approved in Europe for Additional Coronary Indications
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 23 May 2013
InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group
Devices Interventional Cardiology

HSMN NewsFeed - 22 May 2013
OrbusNeich's Genous(TM) Stent Associated With Lower Restenosis Rate Compared to Bare Metal Stents in Low-Risk Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS) Patients
Devices Interventional Cardiology

HSMN NewsFeed - 21 May 2013
Abbott Announces CE Mark for World's Longest Coronary Drug Eluting Stent
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 20 May 2013
OrbusNeich's Genous(TM) Stent Associated With Lower Restenosis Rate Compared to Bare Metal Stents in Low-Risk Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS) Patients
Devices Interventional Cardiology

HSMN NewsFeed - 16 May 2013
St. Jude Medical Announces European Approval of 3-D Vessel Reconstruction Technology to Aid Physicians in Stent Placement
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 2 May 2013
Robotic Angioplasty Achieves 97.6 Percent Clinical Success Rate
Devices Interventional Cardiology

HSMN NewsFeed - 15 Mar 2013
Cardiovascular Systems Completes PMA Submission of Orbital Atherectomy System for Coronary Artery Disease Treatment
Devices Interventional Cardiology FDA

HSMN NewsFeed - 11 Mar 2013
St. Jude Medical Announces Launch of 3-D Vessel Reconstruction Technology in Japan
Devices Interventional Cardiology

HSMN NewsFeed - 14 Feb 2013
Miracor Granted Five Additional U.S. Patents and One Additional European Patent for Its PICSO(R) System to Treat Severe Heart Attack Patients
Devices Interventional Cardiology

HSMN NewsFeed - 30 Jan 2013
Svelte Medical Systems Announces Treatment of First Patient in the DIRECT II Drug-Eluting Stent Study
Devices Interventional Cardiology

HSMN NewsFeed - 9 Jan 2013
Ischemix, Inc. Appoints New Chief Executive Officer
Biopharmaceuticals Cardiology Personnel

HSMN NewsFeed - 9 Jan 2013
Velomedix Receives Health Canada Approval for VELOCITY Pilot Study and Bolsters Leadership Team
Devices Cardiology Regulatory

HSMN NewsFeed - 19 Dec 2012
Regado Biosciences, Inc. Secures $51 Million Series E Financing
Biopharmaceuticals Cardiology Venture Capital

HSMN NewsFeed - 18 Dec 2012
St. Jude Medical Enrolls First Patient in ILUMIEN I Study to Develop Guidance for Stent Optimization
Devices Interventional Cardiology

HSMN NewsFeed - 4 Dec 2012
Clinical study results using Miracor’s PICSO(R) system show potential to treat severe heart attack (STEMI) patients and are published in December’s Journal of Interventional Cardiology
Devices Interventional Cardiology

HSMN NewsFeed - 23 Nov 2012
Volcano Corporation Signs Agreement to Acquire Sync-Rx Ltd.
Devices Interventional Mergers & Acquisitions

HSMN NewsFeed - 14 Nov 2012
Largest Prospective Study Shows IVUS-Guided Stent Placement Improves Patient Outcomes with Current Generation of Stents
Devices Interventional Cardiology

HSMN NewsFeed - 28 Aug 2012
Latest European Heart Attack Treatment Guidelines Recommend Angiomax(R)/Angiox(R) (Bivalirudin) Over Heparin
Biopharmaceuticals Cardiology

HSMN NewsFeed - 27 Aug 2012
MAQUET Cardiovascular Announces Results Of The IABP-SHOCK II Trial Of Intra-aortic Balloon Counterpulsation Therapy In Cardiogenic Shock Patients
Devices Cardiology

HSMN NewsFeed - 25 Jul 2012
FDA Clears First Robotic-Assisted System for Coronary Artery Disease Stent Procedures
Devices Interventional Cardiology FDA

HSMN NewsFeed - 17 May 2012
Early Coronary Artery Healing Advantage of OrbusNeich's Combo Dual Therapy Stent(TM) Compared to the TAXUS(R) Stent Shown in Two Clinical Trial Subgroup Analyses
Devices Interventional Cardiology

HSMN NewsFeed - 14 May 2012
St. Jude Medical Continues Strong Show of PCI Optimization Technologies at EuroPCR
Devices Interventional Cardiology

HSMN NewsFeed - 12 Apr 2012
Abiomed Receives CE Mark for Impella cVAD
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 23 Mar 2012
St. Jude Medical Announces Next-Generation PressureWire for FFR Measurement
Devices Interventional Cardiology FDA

HSMN NewsFeed - 28 Feb 2012
Miracor receives $3.5 million cash infusion to begin pivotal clinical “RAMSES” trial of its PICSO system, designed to improve myocardial perfusion following primary PCI
Devices Interventional Cardiology

HSMN NewsFeed - 24 Jan 2012
Adipose Stem Cell Heart Attack Trial Data Published in Journal of the American College of Cardiology; Cytori's APOLLO Trial Demonstrated Safety & Feasibility and Improvements in Cardiac Function
Regenerative Medicine Cardiology

HSMN NewsFeed - 18 Jan 2012
Independent Data Safety Monitoring Board Recommends St. Jude Medical’s FAME II Clinical Trial Stop Enrollment Following Positive Interim Analysis
Devices Cardiology

HSMN NewsFeed - 5 Jan 2012
OrbusNeich's Genous(TM) Stent Achieves Good, Comparable Clinical Outcomes in Patients Discontinuing Dual Antiplatelet Therapy at 30 Days and at Six Months
Devices Interventional Cardiology

HSMN NewsFeed - 5 Dec 2011
Data Published in EuroIntervention Indicate that OrbusNeich's Genous(TM) Stent Is Safe with Very Short-Term Dual Antiplatelet Therapy
Devices Interventional Cardiology

HSMN NewsFeed - 4 Nov 2011
Miracor to Report Successful Clinical Study Results of Its PICSO(R) System Designed to Improve Myocardial Perfusion Following Primary PCI
Devices Interventional Cardiology

HSMN NewsFeed - 1 Nov 2011
Boston Scientific Announces Schedule of Events at TCT Scientific Symposium
Devices Interventional Cardiology

HSMN NewsFeed - 26 Oct 2011
St. Jude Medical Announces FDA Clearance of First and Only Combined FFR and OCT System
Devices Cardiology FDA

HSMN NewsFeed - 10 Oct 2011
MAQUET Cardiovascular Awarded Three-Year Contract From Premier Healthcare Alliance for Intra-Aortic Balloon Pumps
Devices Cardiology Group Purchasing

HSMN NewsFeed - 19 Sep 2011
Abiomed Announces First Patient Enrolled In MINI-AMI Study
Devices Cardiology

HSMN NewsFeed - 18 Jul 2011
OrbusNeich's Genous Stent Enables Early and Safe Discontinuation of Dual Antiplatelet Therapy in High-Risk Patients Requiring Nondeferrable, Non-Cardiac Surgery
Devices Interventional Cardiology

HSMN NewsFeed - 14 Jul 2011
St. Jude Medical Announces European Approval of First and Only Combined FFR and OCT System
Devices Interventional Cardiology

HSMN NewsFeed - 13 Jul 2011
InfraReDx Initiates a Randomized Clinical Trial of LipiScan IVUS™ Coronary Imaging Guidance to Prevent Heart Attacks During Stenting
Devices Interventional Cardiology

HSMN NewsFeed - 25 May 2011
Boston Scientific Announces FDA Approval and U.S. Launch of PROMUS(R) 2.25 mm Everolimus-Eluting Coronary Stent System
Devices Interventional Cardiology

HSMN NewsFeed - 18 May 2011
Medtronic Resolute(R) Drug-Eluting Stent Offers Strong Performance in Diabetic Patients with Heart Disease
Devices Interventional Cardiology

HSMN NewsFeed - 23 Mar 2011
Data Published in the Journal of Interventional Cardiology Demonstrate Effectiveness and Safety of OrbusNeich's Genous Stent in Diabetic Patients
Devices Interventional Cardiology

HSMN NewsFeed - 15 Mar 2011
Corindus Announces First Robotic-Assisted PCI Procedures in CorPath(R) PRECISE Clinical Trial
Devices Interventional Cardiology

HSMN NewsFeed - 1 Mar 2011
SCAI Publishes Statement on Standards for Quality Assessment and Improvement in Interventional Cardiology
Devices Interventional Cardiology

HSMN NewsFeed - 22 Feb 2011
Published Data From e-HEALING Registry Demonstrate Good Clinical Outcomes With Low Incidence of Repeat Revascularization and Stent Thrombosis for OrbusNeich's Genous Stent
Devices Interventional Cardiology

HSMN NewsFeed - 26 Jan 2011
Corindus Vascular Robotics Announces FDA Conditional Approval for Pivotal Study to Evaluate Robotic-Assisted Placement of Coronary Guidewires and Stent/Balloon Catheters
Devices Interventional Cardiology

HSMN NewsFeed - 26 Jan 2011
Bristol-Myers Squibb and sanofi-aventis Announce U.S. FDA Decision to Grant Pediatric Exclusivity For PLAVIX
Biopharmaceuticals Cardiology Generics FDA

HSMN NewsFeed - 10 Jan 2011
Safety and Efficacy of OrbusNeich's Genous Stent Demonstrated in High-Risk Patients with Known Contraindications for Dual Antiplatelet Therapy
Devices Interventional Cardiology

HSMN NewsFeed - 16 Dec 2010
Economic Evaluation of FAME Trial Confirms Using FFR in Treatment of Coronary Artery Disease Is Cost-Effective
Devices Interventional Cardiology

HSMN NewsFeed - 2 Dec 2010
OrbusNeich's Genous Stent Shows Favorable Outcomes for Treatment of Coronary Artery Bifurcation Lesions Compared to Bare Metal Stents
Devices Interventional Cardiology

HSMN NewsFeed - 2 Dec 2010
Abiomed Receives Conditional FDA Approval for Study with Impella 2.5 in Reducing Heart Muscle Damage Following PCI in STEMI Patients
Devices Interventional Cardiology FDA

HSMN NewsFeed - 16 Nov 2010
Mortality Data Presented for Patients Treated with Effient(R) Who Underwent Isolated Coronary Artery Bypass Surgery
Biopharmaceuticals Cardiology Surgery

HSMN NewsFeed - 16 Nov 2010
GRAVITAS Trial Shows That a Uniform Treatment Strategy of Doubling the Standard Dose of Plavix Does Not Improve Outcomes Post-PCI
Diagnostics Biopharmaceuticals Interventional Cardiology

HSMN NewsFeed - 9 Nov 2010
Miracor reports successful first-in-man clinical outcome for its PICSO(R) system designed to improve acute coronary syndrome (ACS) revascularization following primary percutaneous coronary intervention (PCI)
Devices Interventional Cardiology

HSMN NewsFeed - 20 Sep 2010
Corindus Announces Results of First-in-Human Clinical Study of CorPath(R) 200 System
Devices Interventional Cardiology

HSMN NewsFeed - 31 Aug 2010
New 2010 ESC Guidelines for Percutaneous Coronary Interventions Reinforce Importance of FFR in Treatment of Coronary Artery Disease
Devices Interventional Cardiology

HSMN NewsFeed - 21 Jun 2010
Data Show OrbusNeich's Genous Bio-engineered R stent is Safe and Effective in Combination with Drug-Eluting Balloon
Devices Interventional Cardiology

HSMN NewsFeed - 25 May 2010
Medtronic's Resolute(R) Drug-Eluting Stent Matches Market-Leading Rival in Large Head-to-Head Study
Devices Interventional Cardiology

HSMN NewsFeed - 25 May 2010
St. Jude Medical Enrolls First Patient in FAME II Clinical Trial to Study Use of Fractional Flow Reserve Technology in Patients With Stable Coronary Artery Disease
Devices Interventional Cardiology

HSMN NewsFeed - 25 May 2010
Boston Scientific Announces CE Mark and FDA Approval of NC Quantum Apex Balloon Catheter
Devices FDA Interventional Cardiology Regulatory

HSMN NewsFeed - 20 May 2010
Boston Scientific Announces Schedule for EuroPCR 2010
Devices Interventional Cardiology

HSMN NewsFeed - 22 Apr 2010
Boston Scientific Announces Launch of Kinetix(TM) Guidewire
Devices Interventional Cardiology

HSMN NewsFeed - 16 Mar 2010
Boston Scientific Completes Enrollment in PLATINUM Trials for Small Vessels and Long Lesions
Devices Interventional Cardiology

HSMN NewsFeed - 16 Mar 2010
Study Shows Superior Efficacy for TAXUS(R) Express(R) Stents at One Year Compared to Bare-Metal Stents in Diabetic Patients Experiencing Heart Attack
Devices Interventional Cardiology

HSMN NewsFeed - 15 Mar 2010
Inadequate Response to Clopidogrel Leads to Higher Incidence of Major Adverse Cardiac Events in Patients Who have Undergone PCI
Biopharmaceuticals Diagnostics Cardiology

HSMN NewsFeed - 9 Mar 2010
Bristol-Myers Squibb and AstraZeneca Announce the Commencement of the Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus Trial (SAVOR-TIMI 53)
Biopharmaceuticals Cardiology Endocrinology

HSMN NewsFeed - 1 Mar 2010
Leading interventional cardiologist suggests robotic system from Corindus can potentially raise the standard of care for percutaneous coronary intervention (PCI); podium presentation made at 'CRT 2010'
Devices Interventional Cardiology

HSMN NewsFeed - 9 Feb 2010
Volcano Corporation Completes Acquisition of Lumen Biomedical's Xtract(TM) Thrombus Aspiration Catheter
Devices Interventional Cardiology Acquisitions

HSMN NewsFeed - 1 Feb 2010
OrbusNeich's Genous(TM) Bio-engineered R stent(TM) Demonstrates Good Safety and Clinical Outcomes in Patients with Primary PCI for STEMI
Devices Interventional Cardiology

HSMN NewsFeed - 5 Jan 2010
New Analysis Showed Effient(R) Cost-Effective Compared with Clopidogrel for Patients with Acute Coronary Syndromes Undergoing PCI
Biopharmaceuticals Interventional Cardiology

HSMN NewsFeed - 4 Jan 2010
Boston Scientific Announces Enrollment of First Patient in Post-Approval Study for TAXUS Liberte Stent
Devices Biopharmaceuticals Interventional Cardiology

HSMN NewsFeed - 22 Dec 2009
Volcano Corporation Commends the Elevation of FFR to Level of Evidence A in New PCI Guidelines
Devices Interventional Cardiology

HSMN NewsFeed - 17 Dec 2009
Regado Biosciences, Inc. Completes $40 Million Series D Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 16 Dec 2009
Importance of FFR in Treatment of Coronary Artery Disease Confirmed by New PCI Guidelines
Devices Interventional Cardiology

HSMN NewsFeed - 1 Dec 2009
The Medicines Company Receives European Approval for Angiox(R) (Bivalirudin) for Use in Heart Attack Patients Undergoing Emergency Heart Procedures
Biopharmaceuticals Cardiology Regulatory

HSMN NewsFeed - 18 Nov 2009
New Updates to AHA/ACC/SCAI Clinical Guidelines Recommend Treatment with Effient(R) for Patients with Acute Coronary Syndromes Managed with PCI
Biopharmaceuticals Cardiology

HSMN NewsFeed - 9 Nov 2009
Vascular Solutions Announces 510(k) Clearance and U.S. Launch of GuideLiner Catheter
Devices Interventional Cardiology FDA

HSMN NewsFeed - 16 Oct 2009
Clinical Center of Serbia, Institute for Cardiovascular Diseases Treats First Patient in Trial of Pioneering Stem Cell-Derived Therapy for Heart Failure
Regenerative Medicine Cardiology

HSMN NewsFeed - 24 Sep 2009
Results from Abbott's PROSPECT Study Provide New Insight into Role of Vulnerable Plaque in Coronary Artery Disease
Devices Cardiology

HSMN NewsFeed - 24 Sep 2009
Ticagrelor Reduced Cardiovascular Deaths and Heart Attacks in ACS Patients Undergoing Heart Procedures: New Data from PLATO Trial
Biopharmaceuticals Cardiology

HSMN NewsFeed - 22 Sep 2009
OrbusNeich's Genous(TM) Bio-Engineered R Stent(TM) is Safe in a Broad Population of Patients with Primary PCI for STEMI
Devices Interventional Cardiology

HSMN NewsFeed - 22 Sep 2009
Abiomed Presents Results from USpella; First U.S. Registry Data Evaluating 181 Patients from 16 Centers with IRB Approval
Devices Interventional Cardiology

HSMN NewsFeed - 11 Sep 2009
PLC Medical Systems Reports Strong Success for RenalGuard(R) at ESC 2009
Devices Interventional Cardiology

HSMN NewsFeed - 2 Sep 2009
Two-Year SYNTAX Data Show Comparable Safety Outcomes for Complex Patients Treated With TAXUS(R) EXPRESS(R) Stents and Bypass Surgery
Devices Interventional Cardiology

HSMN NewsFeed - 31 Aug 2009
First Patient Enrolled in CYPRESS, a Dual Antiplatelet Therapy Trial with the CYPHER(R) Sirolimus-Eluting Coronary Stent
Devices Interventional Cardiology

HSMN NewsFeed - 30 Aug 2009
New Large-Scale, Global Study Provides Additional Information About an Intensified Dose-Regimen of Plavix(R) in Acute Coronary Syndrome Patients Undergoing Angioplasty
Biopharmaceuticals Interventional Cardiology

HSMN NewsFeed - 25 Aug 2009
Volcano Corporation and Siemens Healthcare Announce Global Resale Agreement for Volcano IVUS/FFR Systems
Devices Interventional Cardiology

HSMN NewsFeed - 7 Jun 2009
SCAI Statement on the BARI 2D Trial (Bypass Angioplasty Revascularization Investigation With Diabetes Trial) Presented at the American Diabetes Association (ADA) Annual Scientific Sessions and Published in The New England Journal of Medicine
Devices Interventional Cardiology

HSMN NewsFeed - 27 May 2009
FDA Approves Boston Scientific's Next-Generation TAXUS(R) Liberte(R) Atom(TM) Stent System
Devices Interventional Cardiology

HSMN NewsFeed - 21 May 2009
Multiple Types of Heart Attacks Reduced by Prasugrel in TRITON-TIMI 38 Trial
Biopharmaceuticals Cardiology

HSMN NewsFeed - 19 May 2009
SYNTAX Substudy Shows Positive Outcomes for Left Main Patients Treated With TAXUS(R) Express2(R) Stent System
Devices Interventional Cardiology

HSMN NewsFeed - 19 May 2009
Boston Scientific Welcomes Launch of Syntax Score Website
Devices Cardiology

HSMN NewsFeed - 15 May 2009
Boston Scientific Announces Schedule for EuroPCR 2009
Devices Interventional Cardiology

HSMN NewsFeed - 15 May 2009
PLC Medical Systems to Demonstrate RenalGuard(R) at EuroPCR 2009
Devices Interventional Cardiology

HSMN NewsFeed - 13 May 2009
The Medicines Company Discontinues Phase 3 CHAMPION Clinical Trial Program of Cangrelor
Biopharmaceuticals Cardiology

HSMN NewsFeed - 11 May 2009
Journal of American College of Cardiology Article Reports Fewer Repeat Procedures With Boston Scientific's TAXUS(R) Liberte(R) Stent
Devices Interventional Cardiology

HSMN NewsFeed - 7 May 2009
SCAI Releases Consensus Statement on Length of Stay Following Elective Percutaneous Coronary Intervention
Devices Interventional Cardiology

HSMN NewsFeed - 8 Apr 2009
World-First Launch of New Heart Drug
Biopharmaceuticals Interventional Cardiology

HSMN NewsFeed - 30 Mar 2009
FDA Approves Abiomed's New AB Portable Driver; Providing Patient Transport, Mobility and Ambulation without Compromising Performance
Devices FDA Cardiology

HSMN NewsFeed - 26 Mar 2009
Boston Scientific Announces Schedule For ACC 2009
Devices Interventional Cardiology

HSMN NewsFeed - 26 Mar 2009
Cordis Celebrates 50 Years of Transforming Cardiovascular Care
Devices Interventional Cardiology

HSMN NewsFeed - 12 Mar 2009
Schering-Plough's Investigational Oral Thrombin Receptor Antagonist Meets Primary Endpoint in a Newly Published Study
Biopharmaceuticals Cardiology

HSMN NewsFeed - 11 Mar 2009
Journal of the American College of Cardiology Publishes PROTECT I Study Results for Abiomed Impella 2.5
Devices Interventional Cardiology

HSMN NewsFeed - 5 Mar 2009
Abiomed Appoints Michael Howley as Vice President and General Manager of Global Sales and Marketing
Devices Cardiology Personnel

HSMN NewsFeed - 25 Feb 2009
Life-Saving TandemHeart from CardiacAssist Has Now Been Adopted by 100 of the Nation's Elite Cardiac Centers, Including All of the Top-10 as Ranked by U.S. News & World Report
Devices Cardiology

HSMN NewsFeed - 23 Feb 2009
European Commission Approves EFIENT(R) (prasugrel) for Patients with Acute Coronary Syndrome Undergoing PCI
Biopharmaceuticals Cardiology Regulatory

HSMN NewsFeed - 18 Feb 2009
New England Journal of Medicine Publishes Results from Boston Scientific's Landmark SYNTAX(TM) Trial
Devices Interventional Cardiology

HSMN NewsFeed - 3 Feb 2009
Prasugrel Receives Unanimous Approval Recommendation from FDA Advisory Committee
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 15 Jan 2009
Dr. Steven L. Zelenkofske Joins Regado Biosciences as Senior Vice President, Clinical and Medical Affairs and Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 31 Dec 2008
FDA Cardio Renal Advisory Committee to Review Daiichi Sankyo, Lilly Drug Prasugrel
Biopharmaceuticals Cardiology

HSMN NewsFeed - 21 Dec 2008
St. Jude Medical Acquires Radi Medical Systems
Devices Cardiology Mergers & Acquisitions

HSMN NewsFeed - 9 Dec 2008
Portola Pharmaceuticals Initiates Phase II Trial of Novel IV and Oral Anti-Platelet Drug in Non-Urgent Percutaneous Coronary Intervention
Biopharmaceuticals Interventional Cardiology

HSMN NewsFeed - 2 Dec 2008
Ellen McDonald Joins Regado Biosciences as Senior Vice President of Business Operations and Chief Business Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 Nov 2008
FDA Approves Boston Scientific's Apex(TM) PTCA Dilatation Catheter
Devices Interventional Cardiology FDA

HSMN NewsFeed - 12 Oct 2008
Medtronic's Third-Generation Endeavor(R) Resolute Drug-Eluting Stent Maintains Strong Efficacy and Safety Profile at Two Years
Devices Interventional Cardiology

HSMN NewsFeed - 8 Oct 2008
Datascope Announces New Clinical Trial of Intra-Aortic Balloon Counterpulsation in Patients With Acute Myocardial Infarction to Expand Market Utilization
Devices Cardiology

HSMN NewsFeed - 4 Sep 2008
Clinical Data Indicate that Percutaneous Coronary Intervention with the CYPHER(R) Sirolimus-eluting Coronary Stent Is Comparable to Bypass Surgery in Key Safety Measures in Patients with Diabetes and Multi-Vessel Disease
Devices Interventional Cardiology

HSMN NewsFeed - 3 Sep 2008
New Analysis From HORIZONS-AMI Shows Major Bleeding Has a Significant Impact and Contributes to 30-Day Mortality Following Angioplasty in Severe Heart Attack Patients
Biopharmaceuticals Cardiology

HSMN NewsFeed - 3 Sep 2008
Stentys Appoints Rene Spaargaren, MD, as Chief Medical Officer
Devices Interventional Cardiology Personnel

HSMN NewsFeed - 3 Sep 2008
Hadasit's Double Lumen PCI Guiding Catheter Prototype Demonstrates to be the First Guiding Catheter to Successfully Enable Administration of Medicine Directly to the Coronary Artery Throughout the Course of a PCI
Devices Interventional Cardiology

HSMN NewsFeed - 3 Sep 2008
Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel
Biopharmaceuticals Cardiology

HSMN NewsFeed - 2 Sep 2008
New Data Shows Anticlotting Medicine, AGGRASTAT(R), Lowers Incidence of Heart Attack, in Patients Who Respond Poorly to Aspirin or Clopidogrel, after Elective Coronary Angioplasty
Biopharmaceuticals Cardiology

HSMN NewsFeed - 1 Sep 2008
SCAI: CARDia Data Find Diabetic Patients With Complex Heart Disease Can Safely Choose PCI
Devices Interventional Cardiology

HSMN NewsFeed - 1 Sep 2008
SCAI: SYNTAX Data Show PCI Is a Good Option for Patients With Complex Coronary Artery Disease
Devices Interventional Cardiology

HSMN NewsFeed - 1 Sep 2008
Biosensors DES Demonstrates Equivalent Safety and Efficacy to Industry Leading DES in First 'Real World, All Comers' Clinical Study
Devices Interventional Cardiology

HSMN NewsFeed - 1 Sep 2008
Landmark SYNTAX Trial Reports Comparable Safety Outcomes for Complex Patients Treated With TAXUS(R) Express2(TM) Stents or Bypass Surgery
Devices Interventional Cardiology

HSMN NewsFeed - 27 Aug 2008
CYPHER SELECT(R) Plus Sirolimus-eluting Coronary Stent Receives CE Mark Approval for Treatment of Heart Attacks
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 26 Aug 2008
ACUITY 1-Year Sub-Analysis Published in Journal of the American College of Cardiology
Biopharmaceuticals Cardiology

HSMN NewsFeed - 4 Aug 2008
David J. Mazzo, Ph.D., Joins Regado Biosciences as President and CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Jul 2008
Medtronic Starts U.S. Arm of Global Study Comparing Safety of Endeavor(R) and Cypher(R) Drug-Eluting Stents
Devices Interventional Cardiology

HSMN NewsFeed - 28 Jul 2008
OrbusNeich Adds Sapphire(TM) NC Coronary Dilatation Catheter to Product Line-Up
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 21 Jul 2008
Results From the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study
Biopharmaceuticals Cardiology

HSMN NewsFeed - 9 Jul 2008
Portola Completes $60 Million Financing to Advance Its Therapeutic Programs
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 7 Jul 2008
Data Presented at Annual Meeting of Japanese Society of Interventional Cardiology Demonstrate OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) Has Better Outcomes When Compared to Drug-Eluting Stents
Devices Interventional Cardiology

HSMN NewsFeed - 24 Jun 2008
Portola Pharmaceuticals Names William Lis Vice President of Business Development and Commercial Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Jun 2008
Over and Under(R) Pericardium Covered Stent is now in use in England and Proves Great Deliverability
Devices Interventional Cardiology

HSMN NewsFeed - 30 May 2008
PLC Systems Announces Approval of First European Study to Evaluate RenalGuard(TM)
Devices Interventional Cardiology

HSMN NewsFeed - 28 May 2008
The Medicines Company Receives FDA Review Letter for Angiomax Supplemental Filing
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 22 May 2008
Results Published in New England Journal of Medicine Show Angiomax Improved Net Clinical Outcomes and Resulted in Improved Survival Rates in the Most Severe Heart Attack Patients
Biopharmaceuticals Cardiology

HSMN NewsFeed - 13 May 2008
Cardiovascular Researchers Use MEDIHONEY(TM) on Sternal Infections Following Open-Heart Procedures
Biopharmaceuticals Wound Care

HSMN NewsFeed - 13 May 2008
Thrombus Aspiration before Stenting Benefits Patients Suffering Myocardial Infarction, Study Shows
Devices Interventional Cardiology

HSMN NewsFeed - 15 Apr 2008
Cardium's Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack
Devices Cardiology

HSMN NewsFeed - 3 Apr 2008
Medicure Comments on Positive AGGRASTAT Results Presented at the American College of Cardiology Annual Scientific Session
Biopharmaceuticals Cardiology

HSMN NewsFeed - 30 Mar 2008
Heart Attack Patients Benefit From Thrombus Aspiration Prior to Stenting, Study Shows
Devices Interventional Cardiology

HSMN NewsFeed - 30 Mar 2008
BRAVE-3 Questions Value of Abciximab in PCI for Heart Attack
Biopharmaceuticals Interventional Cardiology

HSMN NewsFeed - 30 Mar 2008
Filter Fails to Improve PCI Outcomes in Acute Coronary Syndromes
Devices Interventional Cardiology

HSMN NewsFeed - 30 Mar 2008
Device That Clears Debris From Artery Aids Blood Flow in PCI
Devices Interventional Cardiology

HSMN NewsFeed - 30 Mar 2008
Drug-Eluting Stents Outperform Bare Stents in Heart Attack
Biopharmaceuticals Interventional Cardiology

HSMN NewsFeed - 29 Mar 2008
Study Results Show Investigational Drug, Prasugrel, Cuts Risk of Stent-Related Clots by More than Half Versus Clopidogrel
Biopharmaceuticals Interventional Cardiology

HSMN NewsFeed - 29 Mar 2008
Tailored Clopidogrel Dosing Improves PCI Outcomes
Biopharmaceuticals Interventional Cardiology

HSMN NewsFeed - 29 Mar 2008
Angiomax Demonstrated Improved Outcomes in Acute Heart Attack Patients Undergoing Primary Angioplasty Independent of Individual Risk Factors
Biopharmaceuticals Interventional Cardiology

HSMN NewsFeed - 29 Mar 2008
ISAR-REACT 3 Pits Bivalirudin vs. Unfractionated Heparin in PCI
Biopharmaceuticals Interventional Cardiology

HSMN NewsFeed - 19 Mar 2008
Bifurcated Stent Company Stentys Completes $18 Million 'Series B' Venture Financing
Devices Interventional Cardiology Venture Capital

HSMN NewsFeed - 17 Mar 2008
Abiomed Receives Conditional FDA Approval for Impella 2.5 Study for Acute Myocardial Infarction (AMI) Patients
Devices Cardiology FDA

HSMN NewsFeed - 4 Mar 2008
TherOx Raises $30 Million in Preferred Equity Financing
Devices Interventional Cardiology Venture Capital

HSMN NewsFeed - 27 Feb 2008
Medtronic Announces First Human Use of Its Bifurcation Stent
Devices Interventional Cardiology

HSMN NewsFeed - 15 Feb 2008
OrbusNeich's Genous(TM) Bio-Engineered R Stent(TM) is Feasible in Acute Myocardial Infarction Patients, American Heart Journal Paper Reports
Devices Interventional Cardiology

HSMN NewsFeed - 31 Jan 2008
Stentys bifurcated stent is successfully implanted for the first time at the Rotterdam ThoraxCenter
Devices Interventional Cardiology

HSMN NewsFeed - 10 Jan 2008
OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) has Lower MACE Rate than TAXUS(R) and CYPHER(R) Stents in Clinical Trial
Devices Interventional Cardiology

HSMN NewsFeed - 2 Jan 2008
Barr Confirms Patent Challenge of Argatroban(R)
Biopharmaceuticals Litigation

HSMN NewsFeed - 18 Dec 2007
Harvard University Completes Clinical Study of Pegasus HeartVue 6S System Heart Screening Device
Devices Cardiology

HSMN NewsFeed - 13 Dec 2007
PCI Guideline Update Stresses Long-Term Anticoagulant Therapy After Treatment With Drug-Eluting Stents
Devices Interventional Cardiology

HSMN NewsFeed - 4 Dec 2007
Journal of the American Medical Association (JAMA) Publishes One-Year ACUITY Trial Results
Biopharmaceuticals Cardiology

HSMN NewsFeed - 3 Dec 2007
Texas Heart Institute at St. Luke's Episcopal Hospital Participates in Ground-Breaking Heart Recovery Technology Study
Devices Cardiology

HSMN NewsFeed - 6 Nov 2007
COURAGE Sub-study: PCI Outperforms Drugs-Only
Devices Interventional Cardiology

HSMN NewsFeed - 4 Nov 2007
In Landmark Phase III Head-to-Head Study, Prasugrel Statistically Superior to Clopidogrel in Reducing Risk of Heart Attack
Biopharmaceuticals Interventional Cardiology

HSMN NewsFeed - 24 Oct 2007
Angiomax(R) / Angiox(R) (bivalirudin) Significantly Improved Net Outcomes in Heart Attack Patients
Biopharmaceuticals Cardiology

HSMN NewsFeed - 23 Oct 2007
TherOx(TM) AMIHOT II Pivotal Trial Meets Endpoints
Devices Interventional Cardiology

HSMN NewsFeed - 23 Oct 2007
Adoption of Drug-Eluting Stents Associated with Lower Health Care Costs and Improved Clinical Outcomes
Devices Interventional Cardiology

HSMN NewsFeed - 22 Oct 2007
Volcano Sponsors First Study Designed to Determine if IVUS Can Identify Patients at Risk for Stent Thrombosis and to Demonstrate the Benefit of IVUS Guidance for Procedural Outcome
Devices Interventional Cardiology

HSMN NewsFeed - 22 Oct 2007
Patient Enrollment Complete in First Trial to Compare Physiologic Guidance vs. Angiographic Guidance of Stent Deployment in Patients with Multivessel Disease
Devices Interventional Cardiology

HSMN NewsFeed - 22 Oct 2007
Schering-Plough Reports Two Phase II Studies of Thrombin Receptor Antagonist (TRA) Build on Findings from Previous Phase II Study
Biopharmaceuticals Cardiology

HSMN NewsFeed - 21 Oct 2007
Plavix(R) Indications Expanded in Japan to Include Patients with Acute Coronary Syndrome for Whom Percutaneous Coronary Intervention Is Being Planned
Biopharmaceuticals Cardiology Regulatory

HSMN NewsFeed - 17 Oct 2007
Cordis Corporation Announces Clinical Studies and Events at TCT 2007
Devices Interventional Cardiology

HSMN NewsFeed - 2 Oct 2007
Coherex Medical to Begin its COHEREX-EU Study to Pursue CE Mark Clearance for its Coherex FlatStent PFO Closure System
Devices Interventional Cardiology

HSMN NewsFeed - 1 Oct 2007
TherOx(TM) Announces Completion of Pivotal Trial
Devices Interventional Cardiology

HSMN NewsFeed - 27 Sep 2007
FDA Approves New 300mg Loading Dose Tablet for PLAVIX(R) (clopidogrel bisulfate)
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 24 Sep 2007
First-in-Man Milestone Reported for the Stentys Bifurcated Drug-Eluting Stent
Devices Interventional Cardiology

HSMN NewsFeed - 24 Sep 2007
FDA Accepts sNDA for Expanded Use of Angiomax(R) (bivalirudin)
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 21 Sep 2007
The CYPHER(R) Sirolimus-Eluting Coronary Stent Outperforms the Taxus Stent in Small Coronary Vessels According to New Clinical Data Analysis Published in the Journal of the American College of Cardiology
Devices Interventional Cardiology

HSMN NewsFeed - 11 Sep 2007
Stereotaxis' Niobe System Used to Perform More Than 10,000 Procedures Worldwide
Devices Cardiology

HSMN NewsFeed - 2 Sep 2007
Angiox(R) (Bivalirudin) Alone Reduced Early Bleeding and Resulted in Similar One-Year Mortality Compared to Heparins Plus GP IIb/IIIa Combination Therapy in ACS Patients Undergoing Angioplasty
Biopharmaceuticals Cardiology

HSMN NewsFeed - 2 Sep 2007
New Study Findings Confirm CLEXANE(R)/LOVENOX(R) Long-Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome
Biopharmaceuticals Cardiology

HSMN NewsFeed - 30 Aug 2007
Abiomed Receives Conditional FDA Approval for Impella 2.5 Pivotal Study at up to 150 Hospitals
Devices Cardiology

HSMN NewsFeed - 7 Aug 2007
The Medicines Company Submits Angiomax(R) (Bivalirudin) sNDA to Expand Label to Include ACUITY Data
Biopharmaceuticals Cardiology

HSMN NewsFeed - 27 Jul 2007
Positive Aggrastat(R) Results Versus Integrilin(R) Featured in American Heart Journal
Biopharmaceuticals Interventional Cardiology

HSMN NewsFeed - 18 Jul 2007
Abiomed Announces Canadian Regulatory Approvals of Impella Circulatory Support Technologies
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 2 Jul 2007
The Medicines Company Reacquires Angiox(R) (Bivalirudin) Rights in Europe from Nycomed
Biopharmaceuticals Cardiology

HSMN NewsFeed - 18 Jun 2007
Kensey Nash Announces Results of EU Coronary Study Using the Thromcat(TM) Thrombectomy Catheter System
Devices Interventional Cardiology

HSMN NewsFeed - 14 Jun 2007
Philips Ships Landmark 3,000th Brilliance CT System and Showcases Continued Innovations to Flagship Line of Scanners and Solutions
Devices Radiology

HSMN NewsFeed - 5 Jun 2007
Health Canada's approval of an expanded indication for PLAVIX(R) (clopidogrel bisulfate) now offers protection from all types of heart attacks
Biopharmaceuticals Cardiology Regulatory

HSMN NewsFeed - 22 May 2007
InspireMD Announces Enrollment of 19 Patients in its First in Man Study
Devices Interventional Cardiology

HSMN NewsFeed - 21 May 2007
Five-Year Fractional Flow Reserve Data Confirms Benefit of Deferral of Stenting
Devices Interventional Cardiology

HSMN NewsFeed - 18 May 2007
FDA Approves Lovenox(R) (Enoxaparin Sodium Injection) for the Most Severe Type of Heart Attack
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 18 May 2007
Medtronic Announces Schedule of Activities at EuroPCR
Devices Interventional Cardiology

HSMN NewsFeed - 15 May 2007
Stentys to Report Acute Results of Preclinical Testing With Its Bifurcated Stent
Devices Interventional Cardiology

HSMN NewsFeed - 9 May 2007
Study by Cardiologists at Northwestern Memorial Reveals a High Percentage of Heart Patients Receive Off-Label and Untested Drug-Coated Stents
Devices Interventional Cardiology

HSMN NewsFeed - 7 May 2007
Portola Pharmaceuticals, Inc. Announces Completion of $70 Million Series C Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 26 Apr 2007
Boston Scientific Announces Completion of Enrollment in Landmark Clinical Trial Comparing Drug-Eluting Stents To Cardiac Surgery
Devices Interventional Cardiology

HSMN NewsFeed - 18 Apr 2007
Schering-Plough Announces Initiation of Two Phase III Clinical Trials for Novel Selective Antiplatelet Therapy (TRA-SCH 530348)
Biopharmaceuticals Cardiology

HSMN NewsFeed - 4 Apr 2007
Portola Pharmaceuticals Announces Positive Phase II Results for PRT054021 for Prevention of Venous Thromboembolism Following Total Knee Replacement Surgery
Biopharmaceuticals

HSMN NewsFeed - 27 Mar 2007
SCAI Leaders Say Courage Results Unlikely to Change Use of PCI
Devices Biopharmaceuticals Interventional Cardiology

HSMN NewsFeed - 26 Mar 2007
Philips and Volcano Corporation to Collaborate to Strengthen Cardiovascular Imaging Systems
Devices Cardiology

HSMN NewsFeed - 26 Mar 2007
Two-Year Patient Registry Results Support Safety and Efficacy of CYPHER(R) Sirolimus-Eluting Coronary Stent in 'Real World' Uses
Devices Interventional Cardiology

HSMN NewsFeed - 26 Mar 2007
ACUITY One-Year Findings Meet All Primary Endpoints in Favor of Angiomax(R) (Bivalirudin) Alone Treatment Group
Biopharmaceuticals Cardiology

HSMN NewsFeed - 26 Mar 2007
Philips Speeds Care and Improves the Patient Experience Throughout Cardiac Care Cycles
Devices Cardiology Radiology

HSMN NewsFeed - 24 Mar 2007
Schering-Plough's Novel Oral Thrombin Receptor Antagonist Meets Primary Endpoint in Phase II Trial
Biopharmaceuticals Cardiology

HSMN NewsFeed - 22 Mar 2007
First Patient Enrolled in RAPID MI-ICE Study Employing InnerCool's Endovascular Temperature Modulation Therapy for Heart Attack
Devices Cardiology

HSMN NewsFeed - 16 Mar 2007
First Patients Treated In RenalGuard(TM) Investigational Study By PLC Medical Systems
Devices Interventional

HSMN NewsFeed - 21 Feb 2007
Stentys Appoints Luc Morisset as Director of Regulatory Affairs
Devices Interventional Cardiology Personnel

HSMN NewsFeed - 7 Feb 2007
FDA Grants Priority Review to Lovenox(R) (Enoxaparin Sodium Injection) Supplemental New Drug Application (sNDA) for Acute Heart Attack
Biopharmaceuticals Cardiology

HSMN NewsFeed - 16 Jan 2007
Enrollment Completed in Pivotal Phase III Study Comparing Prasugrel to Clopidogrel in Patients With Acute Coronary Syndrome
Biopharmaceuticals Cardiology

HSMN NewsFeed - 4 Jan 2007
Stentys Receives 'Seed' Financing From Sofinnova Partners
Devices Venture Capital Interventional Cardiology

HSMN NewsFeed - 12 Dec 2006
Medicure Announces Special Protocol Assessment With the FDA For Phase III MEND-CABG II Study
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 7 Dec 2006
Data Presented To FDA Panel Show TAXUS Drug-Eluting Stents as Safe as Bare-Metal Stents and Far More Effective in Reducing Repeat Procedures
Devices Interventional Cardiology FDA

HSMN NewsFeed - 6 Dec 2006
CoreValve announces that its 18-French ReValving(TM) Phase III international clinical trial is now one-third enrolled since commencing less than three months ago
Devices Cardiology

HSMN NewsFeed - 4 Dec 2006
Largest Prospective Study of Microvolt T-Wave Alternans Demonstrates This Technology's Predictive Value for Sudden Cardiac Death in Patients With Preserved Left Ventricular Function After Acute Myocardial Infarction
Devices Cardiology

HSMN NewsFeed - 22 Nov 2006
The New England Journal of Medicine Publishes Angiomax(R) (Bivalirudin) ACUITY Trial Results
Biopharmaceuticals Cardiology

HSMN NewsFeed - 14 Nov 2006
Medicure Announces New AGGRASTAT(R) Data at 2006 Scientific Sessions of the American Heart Association
Biopharmaceuticals Interventional Cardiology

HSMN NewsFeed - 13 Nov 2006
Large Outcomes Study Showed Merck's ARCOXIA(R) (etoricoxib) had Similar Rates of Cardiovascular Thrombotic Events Compared to Diclofenac, the Most Prescribed Traditional NSAID Worldwide
Biopharmaceuticals

HSMN NewsFeed - 1 Nov 2006
MediciNova Announces the Acquisition of Two Novel Antithrombotic Agents from Meiji Seika Kaisha, Ltd.
Biopharmaceuticals Cardiology Acquisitions

HSMN NewsFeed - 24 Oct 2006
Cardium Reports on Positive Effects of Hypothermia Following Heart Attack and Announces Clinical Study to Be Co-Sponsored by Swedish Cardiology Center
Devices Interventional Cardiology

HSMN NewsFeed - 24 Oct 2006
Data Presented by Independent Physician Panel Confirms Low Rate of Thrombosis with Medtronic Endeavor Drug-Eluting Stent
Devices Interventional Cardiology

HSMN NewsFeed - 23 Oct 2006
New Study Shows Prasugrel Achieves Faster Onset and Higher Levels of Platelet Inhibition than Clopidogrel at Approved or Higher Doses
Biopharmaceuticals Cardiology

HSMN NewsFeed - 19 Oct 2006
InfraReDx Announces FDA Clearance of its Near Infrared Spectroscopic System for Examining Coronary Arteries
Devices Interventional Cardiology

HSMN NewsFeed - 4 Oct 2006
The Medicines Company Commences Phase III Clinical Trial of Cangrelor
Biopharmaceuticals Interventional Cardiology

HSMN NewsFeed - 14 Sep 2006
MIV Therapeutics Names Harvard Interventional Cardiologist Dr. Joseph Carrozza to Scientific Advisory Board
Devices Interventional Cardiology Personnel

HSMN NewsFeed - 7 Sep 2006
The New England Journal of Medicine Publishes the STEEPLE Study Which Demonstrated Superior Safety Profile of LOVENOX(R)(Enoxaparin Sodium Injection) Vs. Unfractionated Heparin in Patients Undergoing Non-Emergent Percutaneous Coronary Intervention (PCI)
Biopharmaceuticals Interventional Cardiology

HSMN NewsFeed - 19 May 2006
Biovail to Promote Novartis' Lescol(R) Franchise in Canada; Lescol(R) Provides Treatment Option for Patients Who Need a Statin to Reduce Cardiovascular Risk
Biopharmaceuticals

HSMN NewsFeed - 12 May 2006
Acadesine Reduces Two-year Mortality Following Heart Attacks in Heart Bypass Patients
Biopharmaceuticals Cardiology

HSMN NewsFeed - 11 May 2006
Medtronic Announces Schedule of Activities At EuroPCR
Devices Interventional Cardiology

Return to NewsFeed

Additional items found! 111

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 111 additional stories matching:
percutaneous coronary intervention
(Password required)

FindReps - available on the Apple App Store for iPhone and iPad.